13.01.2011 • News

Thermo Fisher To Pursue Sale Of Lab-Testing Units

Thermo Fisher Scientific, a maker of scientific instruments, is pursuing a sale of two lab-testing divisions that may fetch up to $1 billion, Bloomberg said, citing three people familiar with the matter.

Thermo Fisher has hired Goldman Sachs to handle the sale of Athena Diagnostics, which may be sold for $600-$700 million, and Barclays Capital to help it sell Lancaster Labs, which may fetch $200-$300 million, Bloomberg said.

In December, Thermo Fisher agreed to buy Dionex Corp for $2.1 billion to broaden its lab equipment and environmental safety offerings and boost its presence in Asia.

Thermo Fisher was not immediately available for comment outside of regular U.S. business hours.

Company

Logo:

Thermo Fisher Scientific

81 Wyman Street
02454 Waltham, MA
US

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read